Skip to main content

ORIGINAL RESEARCH article

Front. Public Health
Sec. Aging and Public Health
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1453144

Association of metabolic score for insulin resistance with incident metabolic syndrome: a cohort study in middle-aged and elderly Chinese population

Provisionally accepted
Qiuling Zhang Qiuling Zhang 1*Yushuang Wei Yushuang Wei 2,3Shengzhu Huang Shengzhu Huang 3Yemei Mo Yemei Mo 1*Boteng Yan Boteng Yan 3,4Xihui Jin Xihui Jin 3,4Mingjie Xu Mingjie Xu 3,4Xiaoyou Mai Xiaoyou Mai 2,3*Chaoyan Tang Chaoyan Tang 1*Haiyun Lan Haiyun Lan 1*Rongrong Liu Rongrong Liu 1*Mingli Li Mingli Li 3*Zengnan Mo Zengnan Mo 3*Wenchao Xie Wenchao Xie 1*
  • 1 The First People’s Hospital of Yulin, Yulin, Shaanxi Province, China
  • 2 School of Public Health, Guangxi Medical University, Nanning, Guangx, China
  • 3 Guangxi Key Laboratory of Genomics and Personalized Medicine Research, Guangxi Medical University, Nanning, Guangxi Zhuang Region, China
  • 4 Department of Nephrology, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi Zhuang Region, China

The final, formatted version of the article will be published soon.

    Background: Recent studies suggest that the metabolic score for insulin resistance (MetS-IR) is an effective indicator of metabolic disorders. However, evidence on the relationship between MetS-IR and metabolic syndrome (MetS) among the Chinese middle-aged and elderly population is limited.Objective: This cohort study aims to assess the associations of MetS-IR levels with MetS risk and its components. Methods: Data used in this study from the National Basic Public Health Service Project Management System (2020-2023). Multivariable Cox proportional hazards model and restricted cubic spline (RCS) were employed to evaluate the associations of baseline MetS-IR levels with MetS risk and its components, receiver operating characteristic (ROC) curves were further utilized to assess the efficacy of MetS-IR in predicting the risk of MetS and its component. Results: Of 1498 subjects without MetS at baseline, 392 incident MetS cases were observed during a median of 27.70 months of follow-up. The adjusted multivariable Cox regression analysis indicated an elevated 15% risk of developing MetS for 1-SD increment of MetS-IR [hazard ratios (HRs) and 95% confidence intervals: 1.16 (1.13-1.18)]. Compared to the first tertile of MetS-IR,the HRs of the third tertile and second tertile were 6.31 (95% CI 4.55-8.76) and 2.72 (95% CI 1.92-3.85), respectively. Consistent findings were further detected across subgroups. Moreover, nonlinear associations were observed between MetS-IR and the risk of MetS, abdominal obesity, and reduced high-density lipoprotein concentration (HDL-C) (Pnonlinear < 0.01), with the cutoff of MetS-IR was 32.89. The area under the curve for MetS-IR in predicting MetS was 0.740 (95% CI 0.713-0.768), which was better than those of other indicators.Our cohort study indicates a positive nonlinear association between MetS-IR with incident MetS, abdominal obesity, and reduced HDL-C, but positive linear associations of MetS-IR and elevated blood pressure(BP), elevated fasting blood glucose(FBG), elevated triglycerides(TG) in middle-aged and elderly people, more studies are warranted to verify our findings.

    Keywords: METS-IR index, metabolic syndrome, Elderly, abdominal obesity, HDL-C (high density lipoprotein)

    Received: 22 Jun 2024; Accepted: 30 Jan 2025.

    Copyright: © 2025 Zhang, Wei, Huang, Mo, Yan, Jin, Xu, Mai, Tang, Lan, Liu, Li, Mo and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Qiuling Zhang, The First People’s Hospital of Yulin, Yulin, Shaanxi Province, China
    Yemei Mo, The First People’s Hospital of Yulin, Yulin, Shaanxi Province, China
    Xiaoyou Mai, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangx, China
    Chaoyan Tang, The First People’s Hospital of Yulin, Yulin, Shaanxi Province, China
    Haiyun Lan, The First People’s Hospital of Yulin, Yulin, Shaanxi Province, China
    Rongrong Liu, The First People’s Hospital of Yulin, Yulin, Shaanxi Province, China
    Mingli Li, Guangxi Key Laboratory of Genomics and Personalized Medicine Research, Guangxi Medical University, Nanning, Guangxi Zhuang Region, China
    Zengnan Mo, Guangxi Key Laboratory of Genomics and Personalized Medicine Research, Guangxi Medical University, Nanning, Guangxi Zhuang Region, China
    Wenchao Xie, The First People’s Hospital of Yulin, Yulin, Shaanxi Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.